Press releases | WebDisclosure

PRESS RELEASE

published on 11/17/2025 at 07:00, 2 months 5 days ago

Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar
Sandoz launches TYRUKO® (natalizumab-sztn) in US, the first and only multiple sclerosis biosimilar, offering cost-effective treatment. TYRUKO® approved for all indications of reference medicine Tysabri®

US Market Multiple Sclerosis Biosimilar Sandoz TYRUKO
PRESS RELEASE

published on 11/17/2025 at 07:00, 2 months 5 days ago

Siegfried announces Chief Financial Officer transition
Siegfried AG announces Chief Financial Officer transition. Tania Micki to succeed Reto Suter as CFO on July 1, 2026, bringing extensive finance experience

Chief Financial Officer Transition Siegfried AG Tania Micki Reto Suter
PRESS RELEASE

published on 11/17/2025 at 07:00, 2 months 5 days ago

Cicor announces strong order intake from Aerospace & Defence customers and completes the acquisition of two Valtronic production sites
Cicor announces strong order intake from Aerospace & Defence customers, completes acquisition of Valtronic production sites

Order Intake Mergers & Acquisitions Cicor Technologies Ltd Aerospace & Defence Valtronic
PRESS RELEASE

published on 11/17/2025 at 07:00, 2 months 5 days ago

Inside Information / Other news releases
Innate Pharma to present at Jefferies Global Healthcare Conference on November 17, 2025. A global biotechnology company focusing on cancer immunotherapies

Biotechnology Immunotherapy Cancer Innate Pharma Jefferies Global Healthcare Conference
PRESS RELEASE

published on 11/17/2025 at 07:00, 2 months 5 days ago

Informations privilégiées / Autres communiqués
Innate Pharma présentera lors de la Jefferies Global Healthcare Conference à Londres le 17 novembre 2025. La société développe des traitements d'immunothérapies contre le cancer

Société Cancer Innate Pharma Jefferies Global Healthcare Conference Immunothérapies
PRESS RELEASE

published on 11/17/2025 at 07:00, 2 months 5 days ago

Pluxee maintient des perspectives positives pour l'exercice 2026, après l'annonce d'une réforme du cadre réglementaire au Brésil
Pluxee maintient des perspectives positives pour l'exercice 2026 après l'annonce d'une réforme du cadre réglementaire au Brésil. Le Groupe anticipe des impacts financiers et révise ses objectifs financiers

Brésil Perspectives Pluxee Réforme Exercice 2026
PRESS RELEASE

published on 11/17/2025 at 07:00, 2 months 5 days ago

Pluxee maintains positive outlook for Fiscal 2026 after regulatory reform announced in Brazil
Pluxee maintains positive outlook for Fiscal 2026 following regulatory reform in Brazil. Evaluates financial implications and updates objectives for mid-year onwards

Brazil Financial Objectives Pluxee Regulatory Reform Fiscal 2026
PRESS RELEASE

published on 11/17/2025 at 06:30, 2 months 5 days ago

Formycon achieves key development milestone with FYB208: Biosimilar candidate for Dupixent® (dupilumab) adds another growth driver to the biosimilar portfolio
Formycon achieves key development milestone with FYB208: Biosimilar candidate for Dupixent® (dupilumab) adds another growth driver to the biosimilar portfolio

Growth Biosimilar Formycon Dupixent FYB208
PRESS RELEASE

published on 11/17/2025 at 03:25, 2 months 5 days ago

CGTN: Reckless words, real consequences: Takaichi crosses the line
Japanese Prime Minister Sanae Takaichi's controversial remarks on Taiwan emergency spark backlash from Japan and China, risking peace and stability in the region

Stability Sanae Takaichi Taiwan Emergency Backlash Peace
REGULATED PRESS RELEASE

published on 11/16/2025 at 20:26, 2 months 6 days ago

Déclaration des transactions sur actions propres réalisées du 27 octobre au 31 octobre 2025
Déclaration des transactions sur actions propres de Derichebourg du 27 au 31 octobre 2025 conformément à la réglementation en vigueur

Actions Propres Transactions Bourse Réglementation Derichebourg

Published on 01/22/2026 at 20:20, 10 minutes ago

Tactical Resources Closes Financing
Published on 01/22/2026 at 19:35, 55 minutes ago

Early Warning Report Filed Pursuant to National Instrument 62-103
Published on 01/22/2026 at 18:37, 1 hour 53 minutes ago

Kootenay Silver Announces Upsize of Bought Deal LIFE Private Placement to Gross Proceeds of C$16.5 Million
Published on 01/22/2026 at 18:20, 2 hours 10 minutes ago

IBC Announces Incentive Stock Option Awards
Published on 01/22/2026 at 15:50, 4 hours 40 minutes ago

Premier American Uranium Announces Upsize of Bought Deal Private Placement to C$13 Million

View all ACCESSWIRE

Published on 01/22/2026 at 20:08, 21 minutes ago

EQS-Adhoc: Discussions between Wacker Neuson SE and Doosan Bobcat Inc. regarding the acquisition of a majority stake and takeover of Wacker Neuson SE will not be continued
Published on 01/22/2026 at 19:08, 1 hour 21 minutes ago

EQS-Adhoc: BASF SE: BASF Group releases preliminary figures for full year 2025
Published on 01/22/2026 at 19:05, 1 hour 25 minutes ago

Verve Group Unifies Jun Group and Captify US Under Verve For Advertisers, Reinforcing its Strategy for Brands and Agencies
Published on 01/22/2026 at 19:00, 1 hour 30 minutes ago

HIAG expects profits to jump in 2025 financial year
Published on 01/22/2026 at 18:37, 1 hour 52 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

View all EQS

Published on 01/22/2026 at 18:00, 2 hours 30 minutes ago

TERACT - Independent expert appointment
Published on 01/22/2026 at 18:00, 2 hours 30 minutes ago

TERACT - Nomination de l’expert indépendant
Published on 01/22/2026 at 18:00, 2 hours 30 minutes ago

2025 revenue
Published on 01/22/2026 at 18:00, 2 hours 30 minutes ago

Chiffre d’affaires 2025
Published on 01/22/2026 at 17:45, 2 hours 45 minutes ago

STEF : Evolution de la gouvernance

View all LES ECHOS COMFI WIRE

News